Further Delineation of Clinical Phenotype of ZMYND11 Variants in Patients with Neurodevelopmental Dysmorphic Syndrome

Genes (Basel). 2024 Feb 19;15(2):256. doi: 10.3390/genes15020256.

Abstract

Intellectual disability with speech delay and behavioural abnormalities, as well as hypotonia, seizures, feeding difficulties and craniofacial dysmorphism, are the main symptoms associated with pathogenic variants of the ZMYND11 gene. The range of clinical manifestations of the ZMYND phenotype is constantly being expanded by new cases described in the literature. Here, we present two previously unreported paediatric patients with neurodevelopmental challenges, who were diagnosed with missense variants in the ZMYND11 gene. It should be noted that one of the individuals manifested with hyperinsulinaemic hypoglycaemia (HH), a symptom that was not described before in published works. The reason for the occurrence of HH in our proband is not clear, so we try to explain the origin of this symptom in the context of the ZMYND11 syndrome. Thus, this paper contributes to knowledge on the range of possible manifestations of the ZMYND disease and provides further evidence supporting its association with neurodevelopmental challenges.

Keywords: ZMYND11; diazoxide; hyperinsulinaemic hypoglycaemia; neurodevelopmental dysmorphic syndrome.

Publication types

  • Case Reports

MeSH terms

  • Abnormalities, Multiple* / diagnosis
  • Abnormalities, Multiple* / genetics
  • Cell Cycle Proteins / genetics
  • Child
  • Co-Repressor Proteins / genetics
  • DNA-Binding Proteins / genetics
  • Humans
  • Intellectual Disability* / diagnosis
  • Intellectual Disability* / genetics
  • Mutation, Missense
  • Phenotype
  • Syndrome

Substances

  • Cell Cycle Proteins
  • Co-Repressor Proteins
  • DNA-Binding Proteins
  • ZMYND11 protein, human

Grants and funding

Contract grant sponsor: SUBZ.C190.24.039 and 2023/ABM/02/00003-00.